Local and regional recurrence is the principal reason for treatment failure in squamous cell carcinoma (SCC) of the head and neck. The conventional method of evaluating surgical margins for cellular atypia does not always predict risk of local recurrence accurately. Immunostaining of surgical margins for tumor markers may provide a more precise evaluation of risk of local recurrence. Paraffin-embedded tissue blocks of surgical margins from 24 patients with oral cavity and oropharyngeal squamous cell carcinoma were immunostained for p53 protein. Fifty-eight percent of the patients had at least one margin stain positive for p53, including eight often patients whose SCC recurred locally. The sample odds ratio test predicted a 5.333 times higher chance of local recurrence with at least one p53 positive surgical margin. The implications of these results for patient management and further investigations will be discussed.
Get full access to this article
View all access options for this article.
References
1.
GreenblattM.S., BennettW.P., HollsteinM.Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res1994; 54: 4855–78.
2.
LevineA.J., PerryM.E., ChangA.The 1993 Walter Hubert lecture: The role of the p53 tumor suppressor gene in tumorigenesis. Br J Cancer1994; 69: 409–16.
3.
OlinerJ.D.Discerning the function of p53 by examining its molecular interactions. Bioessays1993; 15: 703–7.
4.
SelterH., MontenarhM.The emerging picture of p53. Int J Biochem1994; 26: 145–54.
5.
TischlerR.B., CalderwoodS.K., ColemanC.N.Increase in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res1993; 53: 2212–16.
6.
BradfordC.R., ZhuS., WolfG.T.Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Otolaryngol Head Neck Surg1995; 113: 408–12.
7.
NeesM., HomannN., DischerH.Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: A possible molecular basis for the development of multiple tumors. Cancer Res1993; 53: 4189–96.
8.
DolcettiR., DoglioniC., MaestroR.p53 over-expression is an early event in the development of human squamous cell carcinoma of the larynx: Genetic and prognostic implications. Int J Cancer1992; 52: 178–82.
9.
SomersK.D., MerrickM.A., LopezM.E.Frequent p53 mutations in head and neck cancer. Cancer Res1992; 52: 5997–6000.
10.
ShinD.M., KimJ., RoJ.Y.Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res1994; 54: 321–6.
11.
MaestroR., DolcettiR., GasparottoD.High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene1992; 7: 1159–66.
12.
KochW.M., BoyleJ.O., MaoL.p53 gene mutations as markers of tumor spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg1994; 120: 943–7.
13.
BourhisJ., BosqJ., WilsonG.D.Correlation between p53 gene expression and tumor cell proliferation in oropharyngeal cancer. Int J Cancer1994; 57: 458–62.
14.
ZambettiG.P., LevineA.A.A comparison of the biological activities of wild-type and mutant p53. Faseb J1993; 7: 855–65.
15.
FieldJ.K., SpandidosD.A., MalliriA.Elevated p53 expression with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer1991; 64: 573–7.
16.
SomersK.D., SchechterG.L.Genetic alterations in head and neck cancer. Otolaryngol Clin North Am1992; 5: 1065–71.
17.
FieldJ.K., ZoumpourlisV., SpandidosD.A.p53 expression and mutations in squamous cell carcinoma of the head and neck: Expression correlates with the patients’ use of tobacco and alcohol. Cancer Detect Prevent1994; 18: 197–208.
18.
BrennanJ.A., MaoL., HrubanR.H.Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Eng J Med1995; 332: 429–35.
19.
PavelicZ.P., PortugalL.G., GooteeM.J.Retrieval of p53 in paraffin-embeded head and neck tumor tissues. Arch Otolaryngol Head Neck Surg1993; 119: 1206–9.
20.
PavelicA.P., GluckmanJ.L., GapanyM.Improved immunohistochemical detection of p53 protein in paraffin-embeded tisues reveals elevated levels in most head and neck and lung carcinomas: Correlation with clinicopathologic parameters. Antican Res1992; 12: 1389–94.
21.
JesseR., SugarbakerE.Squamous cell carcinoma of the oropharynx: Why we fail. Am J Surg1976; 132: 435–8.
22.
Gandour-EdwardsR.F., DonaldP.J., LieJ.T.Clinical utility of intraoperative frozen section diagnosis in head and neck surgery: A quality assurance perspective. Head Neck1993; 15: 373–6.
23.
LeeG.Detection of residual carcinoma of the oral cavity, oropharynx, hypopharynx and larynx: A study of surgical margins. Trans Am Acad Ophthalmol Otolaryngol1974; 78: 49–53.
24.
ChenT.Y., EmrichL.J., DriscolD.L.The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Oncol Biol Phys1987; 13: 833–7.
25.
ChangE.H., JangY.J., HaoZ.Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy. Arch Otolaryngol Head Neck Surg1997; 123: 507–12.
